Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simcare Biotechnology Group is a Guangzhou-based biotechnology and functional skincare company founded in 2019. The company is best known for its flagship brand, Ximuyuan (溪木源), which specializes in research-backed, natural botanical skincare products tailored specifically for Asian sensitive skin. Simcare utilizes advanced extraction technologies and active ingredients—such as camellia, reishi, conotoxin, and plant extracts—to address skin barrier repair, erythema, acne, and aging. With a strong focus on clinical efficacy and scientific research, Simcare operates the Guangdong Sensitive Skin Care Engineering Technology Research Center and has established itself as a leading brand in the sensitive skincare market. The company is backed by prominent investors including Coatue Management, H Capital, and ZhenFund.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simcare Biotechnology Group.